Founded with a mission to transform IT solutions and bio-enhance products, Disruption Labs operates on a B2B business model. The company partners with multinational corporations and high-growth SMEs in the functional food & beverage and clinical therapeutic markets. Their core services include improving existing product areas or creating entirely new disruptive products through an innovative ingredient delivery platform. Disruption Labs aims to empower consumer packaged goods (CPG) innovators to pioneer next-generation products, elevating product quality and enhancing customer experiences.

Notable affiliated people and investors include industry leaders and venture capitalists who support the company's vision of setting new standards within global industries. Key achievements include successful collaborations with top-tier brands and suppliers, leading to the creation of groundbreaking products that have significantly impacted their respective markets. Disruption Labs' overall impact lies in its ability to help clients overcome market hurdles and unlock the full potential of ingredients, thereby reshaping product offerings and setting new benchmarks in the industry.